Prostatype Genomics AB (FRA:PGO0) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PGO0 Prostatype Genomics AB FRA:PGO0
23 GF Score
Price €0.01
! 5 Warning Signs
View Full Analysis

What is Prostatype Genomics AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PGO0
23GF Score
Prostatype Genomics AB FRA:PGO0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prostatype Genomics AB Business Description

Other Exchanges PROGEN:Sweden
Address Augustendalsvagen 20, Nacka Strand, SWE, 131 52
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.
23GF Score

Get the complete analysis for FRA:PGO0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price